Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Translational Andrology and Urology
|
June 18, 2025
High intratumoral heterogeneity in clear cell renal cell carcinoma is associated with reduced immune response and survival
Qizhou Yang, Yuying Han, Xu Liu, et al.
Molecular Neurobiology
|
June 24, 2026
Epigenetic Dysregulation of the Wnt/β-Catenin Pathway via FTO-m6A in the mPFC Contributes to Autism-Like Behaviors
Liting Xue, Ningxia Zhang, JiaLu Zhao, et al.
Epigenetics
|
October 26, 2024
MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of <i>Grin2a</i> in the mouse prefrontal cortex
Liting Xue, Jialu Zhao, Xu Liu, et al.
Blood
|
June 5, 2014
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis
Liting Xue, John A Pulikkan, Peter J M Valk, et al.
The Journal of Biological Chemistry
|
December 30, 2009
Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes
Kalyani V P Guntur, Adilson Guilherme, Liting Xue, et al.
BMC Genomics
|
March 26, 2022
A comparison of transcriptome analysis methods with reference genome
Xu Liu, Jialu Zhao, Liting Xue, et al.
Neuropharmacology
|
March 13, 2026
The MAP6-NTS axis in hippocampal CA1 regulates synaptic plasticity and memory
Yanan Jia, Jintao Lei, Yunrui Jiang, et al.
Frontiers in Pharmacology
|
September 12, 2022
A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents
Leilei Guo, Xiaokang Qin, Liting Xue, et al.
Breast Cancer Research : BCR
|
August 14, 2023
SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models
Feng Zhou, Guimei Yang, Liting Xue, et al.
BMC Cancer
|
October 23, 2021
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Liting Xue, Xingyuan Gao, Haoyu Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Translational Andrology and Urology
|
June 18, 2025
High intratumoral heterogeneity in clear cell renal cell carcinoma is associated with reduced immune response and survival
Qizhou Yang, Yuying Han, Xu Liu, et al.
Molecular Neurobiology
|
June 24, 2026
Epigenetic Dysregulation of the Wnt/β-Catenin Pathway via FTO-m6A in the mPFC Contributes to Autism-Like Behaviors
Liting Xue, Ningxia Zhang, JiaLu Zhao, et al.
Epigenetics
|
October 26, 2024
MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of <i>Grin2a</i> in the mouse prefrontal cortex
Liting Xue, Jialu Zhao, Xu Liu, et al.
Blood
|
June 5, 2014
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis
Liting Xue, John A Pulikkan, Peter J M Valk, et al.
The Journal of Biological Chemistry
|
December 30, 2009
Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes
Kalyani V P Guntur, Adilson Guilherme, Liting Xue, et al.
BMC Genomics
|
March 26, 2022
A comparison of transcriptome analysis methods with reference genome
Xu Liu, Jialu Zhao, Liting Xue, et al.
Neuropharmacology
|
March 13, 2026
The MAP6-NTS axis in hippocampal CA1 regulates synaptic plasticity and memory
Yanan Jia, Jintao Lei, Yunrui Jiang, et al.
Frontiers in Pharmacology
|
September 12, 2022
A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents
Leilei Guo, Xiaokang Qin, Liting Xue, et al.
Breast Cancer Research : BCR
|
August 14, 2023
SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models
Feng Zhou, Guimei Yang, Liting Xue, et al.
BMC Cancer
|
October 23, 2021
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Liting Xue, Xingyuan Gao, Haoyu Zhang, et al.
Page
of 2